Title: Discovery of 3-(4-bromophenyl)-6-nitrobenzo[1.3.2]dithiazolium ylide 1,1-dioxide as a novel dual cyclooxygenase/5-lipoxygenase inhibitor that also inhibits tumor necrosis factor-alpha production.
Journal: Bioorganic & medicinal chemistry 20100115
Title: Utility of MetaSite in improving metabolic stability of the neutral indomethacin amide derivative and selective cyclooxygenase-2 inhibitor 2-(1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl)-N-phenethyl-acetamide.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20090501
Title: Structural and functional basis of cyclooxygenase inhibition.
Journal: Journal of medicinal chemistry 20070405
Title: Inhibition of cyclooxygenase with indomethacin phenethylamide reduces atherosclerosis in apoE-null mice.
Journal: Biochemical pharmacology 20050801
Title: Studies on the metabolism of the novel, selective cyclooxygenase-2 inhibitor indomethacin phenethylamide in rat, mouse, and human liver microsomes: identification of active metabolites.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20040101
